[Clinical study of a new anti-arrhythmic drug (naphyloxy 1)-4 hydroxy-3 butyramidoxime hydiochloride].
D000284:Administration, Oral; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D000440:Butanols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use; D010091:Oximes / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D000440:Butanols; D009281:Naphthalenes; D010091:Oximes
Etude clinique d'un nouvel anti-arythmisant: le chlorhydrate de (naphyloxy 1)-4 hydroxy-3 butyramidoxime